<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with hematologic <z:hpo ids='HP_0002664'>neoplasias</z:hpo> often have chromosomal aberrations in the cells of their bone marrow or unstimulated blood </plain></SENT>
<SENT sid="1" pm="."><plain>One recurrent abnormality is a deletion of the long arm of chromosome 20, primarily described in <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vera, but later seen in a range of <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We have studied 32 patients with del(20q) as the sole chromosomal aberration, investigating significance of this aberration for the clinical diagnoses, hematologic parameters, and prognoses within this patient group </plain></SENT>
<SENT sid="3" pm="."><plain>According to our results, del(20q) is primarily associated with myeloid disorders, but it is not specific for any certain disease, nor does the proportion of cells with del(20q) correlate with prognosis </plain></SENT>
</text></document>